Home>Corporate>Social Responsibility and Public Welfare

Social Responsibility and Public Welfare

Fosun Pharma has incorporated social responsibility into its long-term business strategy. With a grateful gratitude, Fosun Pharma has been endeavoring to meet the expectations of society, the government, its employees and shareholders throughout its business development.

Social Responsibility Report

Medical assistance against malaria in Africa

By the end of 2020, Fosun Pharma had supplied more than 120 million vials of Artesunate for injection to malaria-endemic regions, saving over 24 million lives, among which most are African children under 5. It was a great contribution to the reduced malaria mortality in Africa. Riding on the advantages of its products, Fosun Pharma has undertaken and engaged more than 50 countries in 10 seminars on malaria prevention and control in developing countries, 6 seminars on drug quality management in developing countries, and minister-level seminars on pharmaceutical supervision and management in developing countries sponsored by the Chinese Ministry of Commerce. These efforts have borne fruits by completing 148 China Aid anti-maiaria medicines.. As a public welfare program against malaria launched in November 2020, Fosun Pharma’s “Malaria Care Initiative” combines its years of efforts on community level malaria education, community welfare and academic training to help the international community, especially Africa, to achieve the vision of “End Malaria for Good”.

STARBUDS initiated to provide life-cycle care for children with rare diseases

Under the guidance of the expert group from Shanghai Scientific Association of Better Birth & Better Upbringing (Shanghai Maternal and Child Health Association), Shanghai Foundation for Rare Disease, and Shanghai High-level Local Universities Key Innovation Team (Child Health Maintenance and Promotion), and under the co-sponsorship by Shanghai Fosun Foundation and Children’s Hospital of Fudan University, the “STARBUDS Care Foundation for Children with Rare Diseases” has launched on December 23, 2020. At the meantime, it marked the beginning of project which is dedicated to providing life-cycle care for more children with rare diseases and raising awareness among public for children with rare diseases.

Educational support of FutureStar for continuous encouragement of college teachers and students

Fosun Pharma’s “FutureStar” initiative has provided continuous support and encouragement for college teachers and students over the years. The persistent efforts in 2020 were made by giving scholarships to teachers and students from the School of Life Sciences of Fudan University, China Pharmaceutical University, Shenyang Pharmaceutical University, Tongji Medical College of HUST, and Xuzhou Medical University. By awarding scholarships in a ceremony, this initiative encourages excellent students to keep seeking knowledge and scaling new heights and drives teachers to work on scientific research and talent training. Through the scholarship program, Fosun Pharma has established deeper collaborations with colleges on training and delivering talent.

“Double Thousand Initiative” – Protecting poor TB patients with love

In response to WHO’s ambitious goal of ending the global TB epidemic by the year 2035 and Chinese government’s “Healthy China 2030” Planning, the Chinese Antituberculosis Association (CATA) established the “Chinese Antituberculosis Foundation” in 2016, and worked with Fosun Foundation and Shenyang Hongqi Pharmaceutical Co., Ltd. to jointly launch the Chinese Antituberculosis Public Welfare Foundation – Assistance to Poor TB Patients, known as “Double Thousand” initiative. The donations of RMB 5 million from the initiative up to 2020 have helped 5,400 poor TB patients across 31 provinces, coupled with over 10 large-scale educational activities for patients and visits to such patients in the countryside. These efforts aroused the strong response among the organizations at various levels of antituberculosis authorities and were highly recognized by leaders of the centers for disease control and anti-tuberculosis associations.

“Doctors Going to Countryside” Program

Starting from August 2018, this program aims to expand the service range the high-quality medical resources can cover, promote their allocation to primary medical institutions for higher medical level, and allow rural residents to see serious illness in counties and minor ones in villages or towns. By the end of 2020, this program has helped 11 poverty-stricken counties by providing over 20 training sessions, both online and offline, that involved over 6,600 grass-roots and rural doctors and free medical services for nearly 2,500 patients. In addition, this program has established a communication platform between primary hospitals and 3A hospitals across the country, and won the recognition by patients in remote areas, rural doctors, township health centers, county hospitals and local health departments and county-level government. In 2020, the program was undertaken through online free clinic where specialists from cardiovascular and cerebrovascular diseases were invited to offer tele-consultation, training courses on chronic diseases, and online free clinic. It involved 15,000 local doctors and 2,000 patients.

汉曲优® Rural Medical Service – Public Welfare Activity for the Health of Rural People

Partnering with Fosun Foundation – Rural Doctor Poverty Alleviation Program, People’s Daily Health platform and the Health Times, Henlius initiated the “汉曲优® Rural Medical Service – Public Welfare Activity”. This program is aimed at improving the medical conditions, clinic level and hospital management capabilities in remote villages, raising awareness among more rural people of major tumor diseases such as breast cancer, and realizing the dream of healthy China. Well-known cancer experts and hospital management teams in China were invited to the program which had a reach to more than 10 counties and townships. In 2020, an expert team trained local rural doctors and villagers on the prevention, diagnosis and treatment of breast cancer and other cancer diseases, and offered consultations on intractable cases. They instructed hospital management and department building, inspected village clinics, and visited rural doctors in need. In doing so, they pave the way for standardized diagnosis and treatment of tumors as tumor prevention and treatment are controlled in the first instance.